Jubilant Life#39;s performance would be driven by market share gains in key radiopharmaceutical products, a ramp-up in CMO business, capacity additions in finished dosages Life Science Chemical segment and opportunities from the supply of ethanol to government, IDBI Capital saidTroubles brew at this pharmacy but analysts see up to 100% return in a year
Jubilant Life#39;s performance would be driven by market share gains in key radiopharmaceutical products, a ramp-up in CMO business, capacity additions in finished dosages Life Science Chemical segment and opportunities from the supply of ethanol to government, IDBI Capital said
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment